Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 13 von 46

Details

Autor(en) / Beteiligte
Titel
High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors
Ist Teil von
  • International journal of molecular sciences, 2017-03, Vol.18 (3), p.478-478
Ort / Verlag
Switzerland: MDPI
Erscheinungsjahr
2017
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
  • An increasing number of neurodegenerative diseases are being found to be associated with the abnormal accumulation of aggregated proteins in the brain. In Parkinson's disease, this process involves the aggregation of alpha-synuclein (α-syn) into intraneuronal inclusions. Thus, compounds that inhibit α-syn aggregation represent a promising therapeutic strategy as disease-modifying agents for neurodegeneration. The formation of α-syn amyloid aggregates can be reproduced in vitro by incubation of the recombinant protein. However, the in vitro aggregation of α-syn is exceedingly slow and highly irreproducible, therefore precluding fast high throughput anti-aggregation drug screening. Here, we present a simple and easy-to-implement in-plate method for screening large chemical libraries in the search for α-syn aggregation modulators. It allows us to monitor aggregation kinetics with high reproducibility, while being faster and requiring lower protein amounts than conventional aggregation assays. We illustrate how the approach enables the identification of strong aggregation inhibitors in a library of more than 14,000 compounds.
Sprache
Englisch
Identifikatoren
ISSN: 1422-0067
eISSN: 1422-0067
DOI: 10.3390/ijms18030478
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_b59ce49cbe9b4e039b070a6c54ef78e1

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX